Discover essential steps to protect and strengthen your lungs, from quitting smoking to breathing exercises that can ...

Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...

Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The ...

Despite ongoing progress, structural racism and health disparities continue to shape healthcare practices in ways healthcare ...

Pulmonary function tests, including forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), are commonly used indicators of disease severity and progression (1). Additionally, ...

Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.

Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.